13.3%; p =0.283) than treated with non-ACE-Is/ARBs agents, although these differences did not reach statistical significance [ 78 ].
← all excerpts
Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways.
1
—
—
13.3%; p =0.283) than treated with non-ACE-Is/ARBs agents, although these differences did not reach statistical significance [ 78 ].